vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and Valaris Ltd (VAL). Click either name above to swap in a different company.

Valaris Ltd is the larger business by last-quarter revenue ($5.2M vs $2.8M, roughly 1.9× DBV Technologies S.A.). Valaris Ltd runs the higher net margin — 13798.1% vs -1195.5%, a 14993.6% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs 158.8%). DBV Technologies S.A. produced more free cash flow last quarter ($-32.6M vs $-34.1M). Over the past eight quarters, Valaris Ltd's revenue compounded faster (29.5% CAGR vs 12.4%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

DBVT vs VAL — Head-to-Head

Bigger by revenue
VAL
VAL
1.9× larger
VAL
$5.2M
$2.8M
DBVT
Growing faster (revenue YoY)
VAL
VAL
+247.1% gap
VAL
405.9%
158.8%
DBVT
Higher net margin
VAL
VAL
14993.6% more per $
VAL
13798.1%
-1195.5%
DBVT
More free cash flow
DBVT
DBVT
$1.5M more FCF
DBVT
$-32.6M
$-34.1M
VAL
Faster 2-yr revenue CAGR
VAL
VAL
Annualised
VAL
29.5%
12.4%
DBVT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DBVT
DBVT
VAL
VAL
Revenue
$2.8M
$5.2M
Net Profit
$-33.2M
$717.5M
Gross Margin
-7850.0%
Operating Margin
-1235.7%
Net Margin
-1195.5%
13798.1%
Revenue YoY
158.8%
405.9%
Net Profit YoY
-8.9%
436.6%
EPS (diluted)
$-0.24
$10.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
VAL
VAL
Q4 25
$5.2M
Q3 25
$2.8M
$5.6M
Q2 25
$1.5M
$700.0K
Q4 24
$-1.7M
Q3 24
$3.9M
Q2 24
$1.2M
$4.8M
Q1 24
$1.4M
$2.6M
Q4 23
$8.9M
$3.1M
Net Profit
DBVT
DBVT
VAL
VAL
Q4 25
$717.5M
Q3 25
$-33.2M
$188.1M
Q2 25
$-41.9M
$115.1M
Q4 24
$133.7M
Q3 24
$64.6M
Q2 24
$-33.1M
$149.6M
Q1 24
$-27.3M
$25.5M
Q4 23
$134.3M
$828.5M
Gross Margin
DBVT
DBVT
VAL
VAL
Q4 25
-7850.0%
Q3 25
-7142.9%
Q2 25
-56428.6%
Q4 24
24529.4%
Q3 24
-11748.7%
Q2 24
-9039.6%
Q1 24
-17007.7%
Q4 23
-12867.7%
Operating Margin
DBVT
DBVT
VAL
VAL
Q4 25
Q3 25
-1235.7%
Q2 25
-2806.2%
Q4 24
Q3 24
Q2 24
-2914.9%
Q1 24
-2029.7%
Q4 23
-134.3%
Net Margin
DBVT
DBVT
VAL
VAL
Q4 25
13798.1%
Q3 25
-1195.5%
3358.9%
Q2 25
-2858.4%
16442.9%
Q4 24
-7864.7%
Q3 24
1656.4%
Q2 24
-2852.4%
3116.7%
Q1 24
-1943.5%
980.8%
Q4 23
1512.8%
26725.8%
EPS (diluted)
DBVT
DBVT
VAL
VAL
Q4 25
$10.13
Q3 25
$-0.24
$2.65
Q2 25
$-0.31
$1.61
Q4 24
$1.86
Q3 24
$0.88
Q2 24
$-0.34
$2.03
Q1 24
$-0.28
$0.35
Q4 23
$-0.11
$11.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
VAL
VAL
Cash + ST InvestmentsLiquidity on hand
$69.8M
$599.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.9M
$3.2B
Total Assets
$110.5M
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
VAL
VAL
Q4 25
$599.4M
Q3 25
$69.8M
$662.7M
Q2 25
$103.2M
$503.4M
Q4 24
$368.2M
Q3 24
$379.3M
Q2 24
$66.2M
$398.3M
Q1 24
$101.5M
$494.1M
Q4 23
$141.4M
$620.5M
Stockholders' Equity
DBVT
DBVT
VAL
VAL
Q4 25
$3.2B
Q3 25
$52.9M
$2.4B
Q2 25
$86.2M
$2.3B
Q4 24
$2.2B
Q3 24
$2.1B
Q2 24
$79.1M
$2.2B
Q1 24
$111.7M
$2.0B
Q4 23
$140.2M
$2.0B
Total Assets
DBVT
DBVT
VAL
VAL
Q4 25
$5.3B
Q3 25
$110.5M
$4.6B
Q2 25
$143.4M
$4.5B
Q4 24
$4.4B
Q3 24
$4.3B
Q2 24
$114.2M
$4.4B
Q1 24
$145.9M
$4.4B
Q4 23
$183.0M
$4.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
VAL
VAL
Operating Cash FlowLast quarter
$-32.4M
$72.2M
Free Cash FlowOCF − Capex
$-32.6M
$-34.1M
FCF MarginFCF / Revenue
-1173.5%
-655.8%
Capex IntensityCapex / Revenue
4.2%
2044.2%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$-138.3M
$159.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
VAL
VAL
Q4 25
$72.2M
Q3 25
$-32.4M
$198.1M
Q2 25
$-33.9M
$120.0M
Q4 24
$124.6M
Q3 24
$193.0M
Q2 24
$-35.1M
$11.5M
Q1 24
$-34.7M
$26.3M
Q4 23
$-13.7M
$96.7M
Free Cash Flow
DBVT
DBVT
VAL
VAL
Q4 25
$-34.1M
Q3 25
$-32.6M
$128.3M
Q2 25
$-33.9M
$52.8M
Q4 24
$12.9M
Q3 24
$111.1M
Q2 24
$-35.8M
$-98.7M
Q1 24
$-36.0M
$-125.0M
Q4 23
$-14.0M
$-366.3M
FCF Margin
DBVT
DBVT
VAL
VAL
Q4 25
-655.8%
Q3 25
-1173.5%
2291.1%
Q2 25
-2316.5%
7542.9%
Q4 24
-758.8%
Q3 24
2848.7%
Q2 24
-3084.0%
-2056.3%
Q1 24
-2560.6%
-4807.7%
Q4 23
-158.2%
-11816.1%
Capex Intensity
DBVT
DBVT
VAL
VAL
Q4 25
2044.2%
Q3 25
4.2%
1246.4%
Q2 25
2.2%
9600.0%
Q4 24
-6570.6%
Q3 24
2100.0%
Q2 24
63.0%
2295.8%
Q1 24
94.9%
5819.2%
Q4 23
4.0%
14935.5%
Cash Conversion
DBVT
DBVT
VAL
VAL
Q4 25
0.10×
Q3 25
1.05×
Q2 25
1.04×
Q4 24
0.93×
Q3 24
2.99×
Q2 24
0.08×
Q1 24
1.03×
Q4 23
-0.10×
0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons